Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice

Jinliang Wang; Lei Shuai; Chong Wang; Renqiang Liu; Xijun He; Xianfeng Zhang; Ziruo Sun; Dan Shan; Jinying Ge; Xijun Wang; Ronghong Hua; Gongxun Zhong; Zhiyuan Wen; Zhigao Bu

doi:10.1007/s13238-020-00767-x

Protein Cell ›› 2020, Vol. 11 ›› Issue (10) : 776 -782. DOI: 10.1007/s13238-020-00767-x

LETTER

Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice

Author information +

History +

PDF (1138KB)

Cite this article

Download citation ▾

Jinliang Wang, Lei Shuai, Chong Wang, Renqiang Liu, Xijun He, Xianfeng Zhang, Ziruo Sun, Dan Shan, Jinying Ge, Xijun Wang, Ronghong Hua, Gongxun Zhong, Zhiyuan Wen, Zhigao Bu. Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein Cell, 2020, 11(10): 776-782 DOI:10.1007/s13238-020-00767-x

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, Wei Q, Yu P, Xu Y, Qi F (2020) The pathogenicity of SARS-CoV-1 2 in hACE2 transgenic mice. Nature.

[2]	Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S (2020) Remdesivir for the treatment of Covid-19- preliminary report. N Engl J Med.

[3]	Dinnon KH III, Leist SR, Schafer A, Edwards CE, Martinez DR, Montgomery SA, West A, Yount BL, Hou YJ, Adams LE, Gully KL (2020) A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures. bioRxiv.

[4]	Gu H, Chen Q, Yang G, He L, Fan H, Deng Y-Q, Wang Y, Teng Y, Zhao Z, Cui Y (2020) Rapid adaptation of SARS-CoV-2 in BALB/c mice: novel mouse model for vaccine efﬁcacy. bioRxiv.

[5]	Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC (2020) Clinical Characteristics of Coronavirus disease 2019 in China. N Engl J Med 382:1708–1720

[6]	Hassan AO, Case JB, Winkler ES, Thackray L, Kafai NM, Bailey AL, McCune BT, Fox JM, Chen RE, Soussi WBA (2020) A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies. Cell.

[7]	Jiang R-D, Liu M-Q, Chen Y, Shan C, Zhou Y-W, Shen X-R, Li Q, Zhang L, Zhu Y, Si H-R (2020) Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensinconverting enzyme 2. Cell.

[8]	Kirchdoerfer RN, Ward AB (2019) Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun 10:2342

[9]	Liu Z, Zheng H, Yuan R, Li M, Lin H, Peng J, Xiong Q, Sun J, Li B, Wu J (2020) Identiﬁcation of a common deletion in the spike protein of SARS-CoV-2. bioRxiv.

[10]	Sun J, Zhuang Z, Zheng J, Li K, Wong RL, Liu D, Huang J, He J, Zhu A, Zhao J, Li X (2020) Generation of a broadly useful model for COVID-19 pathogenesis vaccination, and treatment. Cell.

[11]	Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020a) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271

[12]	Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q (2020b) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395:1569–1578

[13]	World Health Organization (2020) Coronavirus disease (COVID-2019) situation report for 30 June 2020.

[14]	Zhou H, Chen X, Hu T, Li J, Song H, Liu Y, Wang P, Liu D, Yang J, Holmes EC (2020) A novel bat coronavirus reveals natural insertions at the S1/S2 cleavage site of the Spike protein and a possible recombinant origin of HCoV-19. bioRxiv.